A

Adjuvant immune checkpoint blockade revisited

The Lancet Oncology, vol. 24, pp. 717–719

Authors 7

  1. Leiden University · Leiden University Medical Center · Centraal Ziekenfonds (Netherlands)

    Affiliation as printed

    Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands; Medical Department, CZ Health Insurance, Tilburg, Netherlands. Electronic address: sahar.van.waalwijk@cz.nl

    Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands

    Medical Department, CZ Health Insurance, Tilburg, Netherlands

  2. Zorgverzekeraars Nederland

    Affiliation as printed

    Department of Health Policy, Zorgverzekeraars Nederland, Zeist, Netherlands

  3. Centraal Ziekenfonds (Netherlands)

    Affiliation as printed

    Medical Department, CZ Health Insurance, Tilburg, Netherlands

  4. Affiliation as printed

    Medical Department, ONVZ Health Insurance, Houten, Netherlands

  5. Zorginstituut Nederland

    Affiliation as printed

    Scientific Advisory Board, National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands

  6. Leiden University · Leiden University Medical Center · The Netherlands Cancer Institute

    Affiliation as printed

    Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

    Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands

    Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

  7. Leiden University · Leiden University Medical Center

    Affiliation as printed

    Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands

Cited by 8 stored of 8

8 results

No patents citing this paper on Lens.org (checked 2026-10-11).

References 10

10 results